Global InformationPercutaneous tibial nerve stimulation information
| Percutaneous tibial nerve stimulation | |
|---|---|
| Specialty | Urology |
Percutaneous tibial nerve stimulation (PTNS), also referred to as posterior tibial nerve stimulation, is the least invasive form of neuromodulation used to treat overactive bladder (OAB) and the associated symptoms of urinary urgency, urinary frequency and urge incontinence. These urinary symptoms may also occur with interstitial cystitis and following a radical prostatectomy. Outside the United States, PTNS is also used to treat fecal incontinence.
PTNS can be used as a primary therapy. Treatment for overactive bladder and fecal incontinence may begin with pharmacological therapies before PTNS is administered. Unlike the variety of OAB drugs available PTNS is more effective and produces far fewer side-effects.[1] Nearly 80% of patients discontinue use (mean of 4.8 months) of drugs within the first year[2] with as high as 17% of discontinuation being due to adverse side-effects.[3] Neuromodulation is emerging as an effective modality to treat patients who are not successful with conservative methods and its demonstrated efficacy has been the topic of multiple publications.[4][5]
- ^ Andersson KE, Chapple CR, Cardozo L, Cruz F, Hashim H, Michel MC, Tannenbaum C, Wein AJ (July 2009). "Pharmacological treatment of overactive bladder: report from the International Consultation on Incontinence". review. Current Opinion in Urology. 19 (4): 380–94. doi:10.1097/mou.0b013e32832ce8a4. PMID 19448545. S2CID 21857035.
- ^ Gopal M, Haynes K, Bellamy SL, Arya LA (December 2008). "Discontinuation rates of anticholinergic medications used for the treatment of lower urinary tract symptoms". primary. Obstetrics and Gynecology. 112 (6): 1311–8. doi:10.1097/aog.0b013e31818e8aa4. PMID 19037041. S2CID 22495238.
- ^ Hartmann KE, McPheeters ML, Biller DH, Ward RM, McKoy JN, Jerome RN, Micucci SR, Meints L, Fisher JA, Scott TA, Slaughter JC, Blume JD (August 2009). "Treatment of overactive bladder in women". review. Evidence Report/Technology Assessment (187): 1–120, v. PMC 4781496. PMID 19947666.
- ^ Mayer R (January 2010). "Neuromodulation--who, what, when, where and why?". editorial. The Journal of Urology. 183 (1): 17–8. doi:10.1016/j.juro.2009.10.053. PMID 19913830.
- ^ Doggweiler R (November 2010). "Will posterior tibial nerve stimulation replace sacral nerve root stimulation as the salvage management of drug resistant urinary urge incontinence?". editorial. The Journal of Urology. 184 (5): 1835–6. doi:10.1016/j.juro.2010.07.012. PMID 20846687.